Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain

Molecular Brain Research

Volumn 55, Issue 1, 1998, Pages 126-132

  Manzanares, Jorge ^a,b   Corchero, Javier ^a   Romero, Julián ^b   Fernandez Ruiz, J Javier ^b   Ramos, José A ^b   Fuentes, José A ^a  

^a INSTITUTO PLURIDISCIPLINAR   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CP 55,940; Mammillary nucleus; mRNA; Periaqueductal grey; Proenkephalin; R methanandamide; Striatum; Tetrahydrocannabinol; Ventromedial nucleus

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; DRONABINOL; MESSENGER RNA; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; IN SITU HYBRIDIZATION; MALE; MAMMILLARY BODY; NONHUMAN; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE PROBE; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS; THALAMUS VENTRAL NUCLEUS;

ANIMALIA;

EID: 0032579759     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00371-9     Document Type: Article

References (42)

1. V. Abadji, S. Lin, G. Taha, G. Griffin, L.A. Stevenson, R.G. Pertwee, A. Makriyannis, (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability, J. Med. Chem. 37 (1994) 1889-1893.
2. J.J. Anderson, A.M. Kask, T.N. Chase, Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists, Eur. J. Pharmacol. 295 (1996) 163-168.
3. J.A. Angulo, B.S. McEwen, Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens, Brain Res. Rev. 19 (1994) 1-28.
4. M.J. Christie, J.T. Williams, P.B. Osborne, C.E. Bellchambers, Where is the locus in opioid withdrawal?, Trends Pharmacol. Sci. 18 (1997) 134-140.
5. S. Choi, C. Horley, S. Aguila, M.F. Dallman, The hypothalamic ventromedial nuclei couple activity in the hypothalamo-pituitary-adrenal axis to the morning fed state, J. Neurosci. 16 (1996) 8170-8180.
6. 9-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus, Eur. J. Pharmacol. 323 (1997) 193-195.
7. 9-tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat, Life Sci. 61 (1997) PL39-PL43.
8. W.A. Devane, F.A. Dysarz III, M.R. Johnson, L.S. Melvin, A.C. Hewlett, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol. 34 (1988) 605-613.
9. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, R.G. Stevenson, G. Griffin, D. Gibson, L.A. Mandelbaum, A. Etinger, R. Mechoulam, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258 (1992) 1946-1949.
10. W.L. Dewey, Cannabinoid pharmacology, Pharmacol. Rev. 38 (1986) 151-178.
11. E. Fride, R. Mechoulam, Pharmacological activity of the cannabinoid receptor agonist anandamide, a brain constituent, Eur. J. Pharmacol. 231 (1993) 447-454.
12. R.P. Hammer Jr., L. Bogic, R.J. Handa, Estrogenic regulation of proenkephalin mRNA expression in the ventromedial hypothalamus of the adult male rat, Mol. Brain Res. 19 (1993) 129-134.
13. R.E. Harlan, B.D. Shivers, G.J. Romano, R.D. Howells, D.W. Pfaff, Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization, J. Comp. Neurol. 258 (1987) 159-184.
14. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. De Costa, K.C. Rice, Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study, J. Neurosci. 11 (1991) 563-583.
15. A.C. Howlett, T.M. Champion-Dorow, I.L. McMahon, T.M. Westlake, The cannabinoid receptor: biochemical and cellular properties in neuroblastoma cells, Pharmacol. Biochem. Behav. 40 (1991) 565-569.
16. S. Inagaki, Y. Kubota, S. Kito, M. Fukuda, T. Ono, M. Yamano, M. Tohyama, Ultrastructural evidence of enkephalinergic input to glucoreceptor neurons in ventromedial hypothalamic nucleus, Brain Res. 378 (1986) 420-424.
17. M.R. Johnson, L.S. Melvin, The discovery of nonclassical cannabinoid analgesics, in: R. Mechoulam (Ed.), Cannabinoids as Therapeutic Agents, CRC Press, Boca Raton, Florida, pp. 121-145.
18. S. Kaymakcalan, I.H. Ayhan, F.C. Tulinay, Naloxone-induced or postwithdrawal abstinence signs in tolerant rats, Psychopharmacology 55 (1987) 243-249.
19. C. Kohler, L.W. Swanson, L. Haglund, J.Y. Wu, The cytoarquitecture, histochemistry and projections of tuberomammillary nucleus in the rat, Neuroscience 16 (1985) 85-110.
20. I. Lengvári, M. Kováks, Z.S. Liposits, M. Szelier, The effect of stimulation of mammillary body on plasma corticosterone in rat, Neuroencrinol. Lett. 6 (1984) 209-285.
21. A.H. Lichtman, B.R. Martin, Spinal and supraspinal components of cannabinoid-induced antinociception, J. Pharmacol. Exp. Ther. 258 (1991) 517-523.
22. A.H. Lichtman, S.A. Cook, B.R. Martin, Investigation of brain sites mediating cannabinoid induced antinociception in rats evidence supporting periaqueductal gray involvement, J. Pharmacol. Exp. Ther. 276 (1996) 585-593.
23. S.L. Lightman, The neuroendocrine paraventricular hypothalamus: receptor, signal transduction, mRNA and neurosecretion, J. Exp. Biol. 139 (1988) 31-49.
24. S.L. Lightman, W.S. Young III, Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat, J. Physiol. 403 (1988) 511-523.
25. P. Mailleux, J.J. Vanderhaeghen, δ-9-tetrahydrocannabinol regulates substance P and enkephalin mRNAs levels in the caudate-putamen, Eur. J. Pharmacol. 267 (1994) R1-R3.
26. 9-THC induces increases in spinal dynorphin A (1-17) and leucine enkephalin, International Cannabinoid Research Society, 1996 Symposium on Cannabis and the Cannabinoids, Abstract, 1996, p. 9.
27. L.A. Matsuda, S.J. Lolait, M.J. Browstein, A.C. Young, T.I. Bonner, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature 346 (1990) 561-564.
28. 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations, Pharmacol. Biochem. Behav. 45 (1993) 291-298.
29. F.E. Pontieri, G. Tanda, G. Di Chiara, Intravenous cocaine, morphine, and methamphetamine preferentially increase extracellular dopamine in the shell compared with the core of the rat nucleus accumbens, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 12304-12308.
30. F.E. Pontieri, G. Tanda, F. Orzi, G. Di Chiara, Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs, Nature 382 (1996) 255-257.
31. G. Pugh Jr., D.J. Mason Jr., V. Combs, S.P. Welch, Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP-55, 940 in the spinal cord, J. Pharmacol. Exp. Ther. 281 (1997) 730-737.
32. I. Reche, J.A. Fuentes, M. Ruiz-Gayo, A role for central cannabinoid and opioid systems in peripheral 4-9-tetrahydrocannabinol-induced analgesia in mice, Eur. J. Pharmacol. 301 (1996) 75-81.
33. F. Rodriguez de Fonseca, M.R.A. Carrera, M. Navarro, G.F. Koob, F. Weiss, Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal, Science 276 (1997) 2050-2054.
34. G.J. Romano, C.V. Mobbs, R.D Howells, D.W. Pfaff, Estrogen regulation of proenkephalin gene expression in the ventromedial hypothalamus of the rat: temporal qualities and synergism with progesterone, Mol. Brain Res. 5 (1989) 51-58.
35. 1 receptor ligand, Life Sci. 58 (1996) 1249-1257.
36. T. Rubino, P. Massi, G. Patrini, I. Venier, G. Giagnoni, D. Parolaro, Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an situ hybridization study, Neuroreport 5 (1994) 2493-2496.
37. G.S. Smith, D. Savery, C. Marden, J.J. Lopez Costa, S. averill, J.V. Priestley, M. Rattray, Distribution of messenger RNAs encoding enkephalin, substance P, somatostatin, galanin, vasoactive intestinal polypeptide, neuropeptide Y, and calcitonin gene-related peptide in the midbrain periaqueductal grey in the rat, J. Comp. Neurol. 350 (1994) 23-40.
38. 1 opioid receptor mechanism, Science 276 (1997) 2048-2050.
39. P.J.J. Vaysse, E.L. Gardner, R.S. Zukin, Modulation of rat brain opioid receptors by cannabinoids, J. Pharmacol. Exp. Ther. 241 (1987) 534-539.
40. G. Vela, M. Ruiz-Gayo, J.A. Fuentes, Anandamide decreases nalox-one-precipitated withdrawal signs in mice chronically treated with morphine, Neuropharmacology 34 (1995) 665-668.
41. M. Yamano, S. Inagaki, S. Kito, M. Tohyama, An enkephalinergic projection from the hypothalamic paraventricular nucleus to the hypothalamic ventromedial nucleus of the rat: an experimental immunohistochemical study, Brain Res. 331 (1985) 25-33.
42. W.S. Young III, T.I. Bonner, M.R. Barnn, Mesencephalic dopaminergic neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 9827-9831.